Xbiotech
Austin‑based XBiotech develops True Human monoclonal antibodies and IL‑1α therapies for inflammatory, infectious and cardiovascular diseases, positioning itself as a growing player in targeted immuno‑therapy.
Headquarters: United States (USA)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Hospitals and Health Care
- Industry: Medical and Diagnostic Laboratories
- Employees: 88
- HQ: Austin
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.